Advances in Skin Cancer Diagnosis: Using New Technologies to Identify High-Risk Patients
Credit(s): 1.00 (60 min)
Release Date: Jun 18, 2021
Expiration Date: Jun 18, 2022
CME / AMA PRA Category 1 Credit™
Physicians/ABIM MOC – ABIM MOC Point(s)
Despite advances in screening and treatment, skin cancer remains a major source of morbidity and mortality in the United States. Early detection and appropriate, risk-adjusted treatment is essential to ensure optimal patient outcomes. Unfortunately, diagnosis and staging of skin cancers like melanoma and cutaneous squamous cell carcinoma (cSCC) can be challenging. Determining the risk status of newly diagnosed patients is particularly important, as it has major implications for treatment selection. Failure to appropriately assess patient risk can lead to either over or undertreatment, negatively impacting patient outcomes. In recent years, novel technologies designed to aid in diagnosis, staging, risk assessment, and treatment decision-making have emerged for melanoma and cSCC, and many more are in development. Use of these tests can help dermatologists in early identification of patients with high-risk disease who may require a more aggressive treatment approach.
This activity, Advances in Skin Cancer Diagnosis: Using New Technologies to Identify High-Risk Patients will review emerging trends in diagnosis and risk stratification for patients with common skin cancers, including melanoma and cSCC, including discussion of current diagnostic strategies, challenges in risk stratification, and clinical applications for new molecular tests designed to identify high-risk patients and aid in treatment decision-making.
Jointly provided by the Potomac Center for Medical Education and Rockpointe
This program is supported by an educational grant from Castle Biosciences, Inc.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.